Advances in medicine, greater longevity and a rapidly expanding world population continue to increase the numbers of people at the risk of infection. The situation compounded by the emergence of multi-drug resistant microbes and the lack of new clinically effective anti- infective agents compelled us to establish Microbiology section under FLS. Research within the Molecular Microbiology Group will be directed towards the acquisition of novel molecular and cellular insights into host pathogen interactions, quorum sensing and the evolution of virulence and drug resistance with a view to the discovery of new therapeutic and preventative strategies against Viral, Bacterial and Fungal Pathogens.